Abstract
We have evaluated the effect of pyridostigmine (PD), a cholinergic agonist, on the growth hormone (GH) response to physical exercise (EXC) in nine healthy volunteers. PD administration and EXC caused a similar increase of GH secretion to mean (±SE) peak values of 5.3±0.9 and 6.5±1.2 μg/l, respectively. Pretreatment with PD caused a significant augmentation of the EXC-induced GH release evaluated both as maximum peak (13.5±2.1 μg/l, p<0.01 vs EXC) and as area under the secretory curve (EXC= 292.6±41.9 μg.min.l; PD+EXC= 587.3± 68.9 μg.min.l, p<0.005). The action of PD on GH secretion was additive to that of EXC since the sum of the GH responses to PD and EXC was not significantly different from the response obtained during PD+EXC. Whether PD and EXC act through a common final pathway, i.e. inhibition of endogenous somatostatin release, or the EXC-induced GH secretion involves stimulation of endogenous GHRH remains matter of investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Müller E.E., Locatelli V., Ghigo E., Cella S.G., Loche S., Arce V., Pintor C., Cocchi D., Camanni F. Neural regulation of growth hormone secretion: animal and human findings. In: Pintor C., Müller E.E., Loche S., New M.I. (Eds.), Advances in pediatric endocrinology. Springer-Verlag-Pythagora Press, Berlin-Milan, 1992, p. 17.
Müller E.E., Locatelli V., Ghigo E., Cella S.G., Loche S., Pintor C., Camanni F. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Drugs 41: 161, 1991.
Locatelli V., Torsello A., Redaelli M., Ghigo E., Massara F., Müller E.E. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. J. Endocrinol. 111: 271, 1986.
Werhenberg W.B., Wiviott S.D., Voltz D.M., Giustina A. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 130: 1445, 1992.
Casanueva F.F., Villanueva L., Dieguez D., Cabranes J.A., Cabezas J., Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, Clonidine and physical exercise in man. J. Clin. Endocrinol. Metab. 59: 526, 1984.
Brillon D., Nabil N., Jacobs L.S. Cholinergic but not serotoninergic mediation of exercise-induced growth hormone secretion. Endocr. Res. 12: 137, 1986.
Moretti C., Fabbri A., Gnessi L., Cappa M., Calzolari A., Fraioli F., Grossman A., Besser G.M. Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin. Endocrinol. (Oxf.) 18: 135, 1983.
Cappa M., Del Balzo P., Rizzoni G., Benedetti S., Borrelli P. Somatostatinergic tone in children with chronic haemodialysis and after renal transplantation. Pediatr. Nephrol. 5: 548, 1991.
Galbo H. The hormonal response to exercise. Proc. Nutr. Soc. 44: 257, 1985.
Joffe B.I., Haitas B., Eldelstein D., Panz V., Lamprey J.M., Baker S.G., Seftel H.C. Clonidine and the hormonal response to graded exercise in healthy subjects. Horm. Res. 23: 136, 1986.
Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F. Blockade of hpGRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 59: 1025, 1984.
Massara F., Ghigo E., Demislis K., Tangolo D., Mazza E., Locatelli V., Müller E.E., Molinatti G.M., Camanni F. Cholinergic involvement in the growth hormone-releasing hormone-induced growth hormone secretion: studies in normal and acromegalic subjects. Neuroendocrinology 43: 670, 1986.
Ghigo E., Mazza E., Imperiale E., Rizzi G., Benso L, Müller E.E., Camanni F., Massara F. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone GH-releasing hormone-induced GH secretion in children of short stature. J. Clin. Endocrinol. Metab. 65: 452, 1987.
Cordido F., Dieguez C., Casanueva F. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by Clonidine, arginine, or hypoglycemia in normal and obese subjects. J. Clin. Endocrinol. Metab. 70: 1361, 1990.
Ghigo E., Goffi S., Mazza E., Imperiale E., Arvat E., Bellone J., Procopio M., Müller E.E., Camanni F. Acute administration of pyridostigmine and Clonidine has an additive effect on GH release in normal children. J. Endocrinol. Invest. 72: 99, 1989.
Alba-Roth J., Müller A.O., Schopohl J., Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 51: 781, 1988.
Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., De Sanctis C., Camanni F. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin. Endocrinol. (Oxf) 32: 763, 1990.
Valcavi R., Dieguez C., Page M.D., Zini M., Casoli P., Portioli I., Scanlon M.F. Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects. Clin. Endocrinol. (Oxf) 29: 309, 1988.
Devesa J., Arce V., Lois N., Tresguerres J.A.F., Lima L. α2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. J. Clin. Endocrinol. Metab. 71: 1581, 1990.
Felsing N.E., Brasel J.O., Cooper D.M. Effect of low and high intensity exercise on circulating growth hormone in men. J. Clin. Endocrinol. Metab. 75: 157, 1992.
Luger A., Watskinger B., Deuster P., Svoboda T., Clodie M., Chrousos G.P. Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion. Neuroendocrinology 56: 112, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cappa, M., Grossi, A., Benedetti, S. et al. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man. J Endocrinol Invest 16, 421–424 (1993). https://doi.org/10.1007/BF03348871
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348871